Chemo-radiation combo may avert prostate cancer recurrenceNovember 5th, 2009 - 2:34 pm ICT by ANI
Washington, Nov 5 (ANI): Radiation therapy, in combination with chemotherapy before prostate removal, has been found safe for cancer patients and may reduce the risk of recurrence, say researchers.
The research team from Oregon Health and Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Centre has shown chemo-radiation combination is feasible and safe and improves survival among prostate cancer patients.
“In men with aggressive prostate cancer, standard therapies such as radiation or surgery often fail to eliminate the cancer completely at the site of treatment. When these cancers recur, they are often fatal,” said Dr Mark Garzotto, principal investigator and Associate Professor of Urology and Radiation Medicine in the OHSU Knight Cancer Institute; and Chief of Urologic Oncology in the Portland Veterans Affairs Medical Centre.
“Novel approaches are needed if we are to make advances in this disease,” he added.
For the study, researchers developed a treatment regimen in which radiation and docetaxel were administered together before prostatectomy.
The twelve men were given intensity-modulated radiation therapy and increasing doses of docetaxel for five consecutive weeks, which was followed by surgical removal of the prostate gland.
They found that the participants tolerated the treatment well and were able to undergo surgery without any major complications. Specifically there were no rectal or ureteral injuries or blood clots in the legs.
Examination of the tumour tissue after surgery showed the cancer margins, evidence of complete removal of all of the cancer, to be clean in 75 percent of patients, which is higher than was expected.
Also, the PSA, or prostate-specific antigen levels, a predictor of prostate cancer recurrence, were undetectable after treatment in all patients.
“Our study is the first-ever clinical trial in prostate cancer to combine radiation, chemotherapy and surgery given as a combination treatment before prostate surgery to potentially provide higher cure rates than traditional approaches with fewer side effects,” said Dr Arthur Hung, M.D., co-investigator and Assistant Professor of Radiation Medicine in the OHSU Knight Cancer Institute.
The findings were presented at 51st annual meeting of the American Society of Therapeutic Radiology and Oncology in Chicago. (ANI)
- Chemo-radiotherapy prevents bladder cancer recurrences - Oct 26, 2010
- Potent anticancer drug isolated from weed - Jul 10, 2012
- Combining radiation therapy, chemo safely treats head and neck cancers - Nov 04, 2010
- Aspirin use 'cuts risk of death from prostate cancer by more than half' - Oct 26, 2010
- Prostate cancer patients should not take dietary supplements - Mar 09, 2010
- Targeted cancer drug more effective after first-line treatment - Feb 28, 2011
- Robot-assisted surgery to remove cancerous prostate glands is safe - Mar 24, 2011
- New procedure busts deadly brain tumour cells - Feb 06, 2012
- Surgery effective for aggressive prostate cancer patients - Sep 28, 2010
- MRI can help locate prostate cancer recurrence at extremely low PSA levels - Apr 30, 2011
- Exercise benefits cancer patients - May 21, 2010
- New standard treatment for breast cancer at early stages established - Dec 04, 2010
- Radiation can prevent cancer relapse after surgery - Nov 06, 2009
- Shark cartilage does not improve lung cancer survival - May 27, 2010
- Prostate cancer screening improves patients' quality of life - Oct 26, 2010
Tags: blood clots in the legs, cancer institute, docetaxel, intensity modulated radiation, intensity modulated radiation therapy, modulated radiation therapy, novel approaches, prostate cancer, prostate cancer patients, prostate cancer recurrence, prostate gland, prostate removal, prostate specific antigen, prostatectomy, radiation medicine, treatment regimen, tumour tissue, twelve men, ureteral, veterans affairs medical